Cargando…

Some recommendations for multi-arm multi-stage trials

Multi-arm multi-stage designs can improve the efficiency of the drug-development process by evaluating multiple experimental arms against a common control within one trial. This reduces the number of patients required compared to a series of trials testing each experimental arm separately against co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wason, James, Magirr, Dominic, Law, Martin, Jaki, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843088/ https://www.ncbi.nlm.nih.gov/pubmed/23242385 http://dx.doi.org/10.1177/0962280212465498

Ejemplares similares

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
por: Jaki, Thomas, et al.
Publicado: (2018)

An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)

Factorial versus multi‐arm multi‐stage designs for clinical trials with multiple treatments
por: Jaki, Thomas, et al.
Publicado: (2016)

Planning multi-arm screening studies within the context of a drug development program
por: Wason, James M S, et al.
Publicado: (2013)

A multi-stage drop-the-losers design for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2016)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Designing multi‐arm multi‐stage clinical trials using a risk–benefit criterion for treatment selection
por: Jaki, Thomas, et al.
Publicado: (2015)

Estimation in multi‐arm two‐stage trials with treatment selection and time‐to‐event endpoint
por: Brückner, Matthias, et al.
Publicado: (2017)

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
por: Magirr, Dominic, et al.
Publicado: (2016)

A web application for the design of multi-arm clinical trials
por: Grayling, Michael J., et al.
Publicado: (2020)

Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
por: Wason, James M S, et al.
Publicado: (2014)

Familywise error control in multi‐armed response‐adaptive trials
por: Robertson, D. S., et al.
Publicado: (2019)

Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks
por: Villar, Sofia S, et al.
Publicado: (2013)

The benefits of covariate adjustment for adaptive multi-arm designs
por: Lee, Kim May, et al.
Publicado: (2022)

Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats
por: Lee, Kim May, et al.
Publicado: (2021)

Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate
por: Wason, James M. S., et al.
Publicado: (2021)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2012)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017)

Bayesian adaptive decision-theoretic designs for multi-arm multi-stage clinical trials
por: Bassi, Andrea, et al.
Publicado: (2020)

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
por: Mossop, Helen, et al.
Publicado: (2021)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis
por: Li, Vivien, et al.
Publicado: (2022)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Systematic review of available software for multi-arm multi-stage and platform clinical trial design
por: Meyer, Elias Laurin, et al.
Publicado: (2021)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Simultaneous confidence intervals that are compatible with closed testing in adaptive designs
por: MAGIRR, D., et al.
Publicado: (2013)

How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
por: Barthel, FM-S, et al.
Publicado: (2009)

Online error rate control for platform trials
por: Robertson, David S., et al.
Publicado: (2023)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

A vascular multi‐arm multi‐stage trial to prevent groin wound surgical site infection: A feasibility survey
por: Popplewell, Matthew A., et al.
Publicado: (2023)

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
por: Boeree, Martin J, et al.
Publicado: (2017)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice
por: Emmerson, Jake, et al.
Publicado: (2021)

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
por: Gonzalez-Robles, Cristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5dli633isbl0pcmlc6prgbupcb